Myron Cohen, MD, the Yeargan-Bate Distinguished Professor of Medicine, Microbiology and Immunology, and Epidemiology, was interviewed by Science Magazine discussing the importance of continuing HIV prevention trials while recognizing the effects that the coronavirus pandemic may have on trial participants.
Cohen, who is the director of the Institute for Global Health & Infectious Diseases and associate vice chancellor for Global Health and Medical Affairs, acknowledges that results of HIV prevention trials depend in part on participants’ risk of contracting the virus, and that social distancing orders that limit intimacy might change that underlying risk.
Read the article here.